Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaIpamorelin

Ipamorelin

Growth-hormone secretagogue

Not ARTG-approved

What it is

A selective growth-hormone secretagogue.

What the evidence shows

Studied in early research as a selective secretagogue. Human clinical evidence for the wellness and performance claims marketed online is limited.

Safety & reported risks

Without oversight, the main risks are product quality and unmonitored hormonal effects. It is prohibited in sport under WADA rules.

Status in Australia

Not ARTG-approved. Sometimes accessed via compounding under prescription; online supply is unregulated.

How it’s lawfully accessed

Not registered. Any legitimate access runs through a prescriber and compounding under tightened TGA rules — not through unregulated supply.

Related peptides

CJC-1295GHRH analogueNot ARTG-approvedSermorelinGHRH analoguePrescription medicineHexarelinGrowth-hormone secretagogueNot ARTG-approved

Frequently asked questions

Is ipamorelin approved in Australia?

No. It is not on the ARTG. It is sometimes discussed under compounding, but TGA rules around compounded peptides have become more restrictive.

Sources & further reading

This entry is general information about Ipamorelin, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.